Personal profile
Biography
|
2025-present |
Professor Oncological Urology, UMC Utrecht |
|
2021-present |
Chairman UMC Utrecht Expertise Centre for testicular and extragonadal germ cell tumors (NFU and ERN eUROGEN) |
|
2018-present |
Head Department Oncological Urology, UMC Utrecht |
|
2018-present |
Associate Professor Oncological Urology, UMC Utrecht |
|
2012-present |
Oncological Urologist, UMC Utrecht |
|
2016-present |
Chairman of the Oncological Urology Tumour Group, UMC Utrecht |
|
2016-present |
Member of the Oncology Committee, UMC Utrecht |
|
2016-present |
Deputy Chief of the Specialist Medical Training Urology, UMC Utrecht |
Current research projects
Research support (institutional)
- Janssen (Research-grant) (2017-2022)
- Roche (Research-grant) (2017-2021)
- Astellas (Research-grant) (2021-2022)
- Merck (Educational-grant) (2022)
- Janssen/Astellas/AstraZeneca/MSD/BMS/Roche/Merck (ProBCI support)
Company Advisory Boards (institutional):
- Merck
- MSD
- Janssen
- Bristol-Myers Squibb Company
2023 Framingham selection Urothelial Cancer Issues (Bristol-Myers Squibb Company; institutional)
External positions
Panelmember EAU Muscle-invasive and Metastatic Bladder Cancer (MIBC) Guidelines Panel - Aandachtsgebied blaaskanker - European Association of Urology
19 Mar 2021 → 31 Dec 3999
Panelmember EAU Guideline Primary Urethral Carcinoma - Europese richtlijn commissie - European Association of Urology
19 Mar 2021 → 31 Dec 3999
Stuurgroep ProBCI - Blaaskanker expertise - Stichting Prospectieve Blaaskanker Infrastructuur (ProBCI)
24 Oct 2019 → 31 Dec 3999
Plaatsvervangend opleider Urologie UMCU - Plaatsvervangend opleider Urologie UMCU - UMCU
12 Oct 2016 → 31 Dec 3999
Associate member of ERUS (EAU Robotic Urology Section) - Associate member of ERUS (EAU Robotic Urology Section) - European Association of Urology
15 Sept 2016 → 31 Dec 3999
Voorzitter UMC Utrecht Expertise Centrum voor testiculaire en extragonadale - Voorzitter UMC Utrecht Expertise Centrum voor testiculaire en extragonadale NFU accreditatie (ECZA) - UMCU
6 Jul 2016 → 31 Dec 3999
Lid van Dutch Uro-Oncological Society (DUOS) - Actief lid van de subgroepen blaaskanker en zaadbalkanker van de DUOS - Dutch Uro-Oncological Society (DUOS)
16 Sept 2015 → 31 Dec 3999
Lid Werkgroep Oncologische Urologie (WOU) van de NVU - Actief lid van de subgroepen blaaskanker en zaadbalkanker van de Werkgroep Oncologische Urologie (WO - Nederlandse Vereniging voor Urologie
15 Jul 2015 → 31 Dec 3999
Associate member of ESOU (EAU Section of Oncological Urology) - Associate member of ESOU (EAU Section of Oncological Urology) - European Association of Urology
13 May 2014 → 31 Dec 3999
Collaborations and top research areas from the last five years
-
AI-based prediction of molecular aberrations in prostate cancer using digital pathology: a systematic review
van Hees, J. E., Vlaming, M., Flach, R. N., Stathonikos, N., Suelmann, B. B. M., Meijer, R. P., Willemse, P.-P. M. & van Diest, P. J., Jan 2026, In: Critical Reviews in Oncology/Hematology. 217, 105011.Research output: Contribution to journal › Review article › peer-review
-
Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway
Vlaming, M., Bleiker, E. M. A., Schijven, G., Kiemeney, L. A. L. M., van Melick, H. H. E., Hunting, J. C. B., Noordzij, M. A., Beeker, A., Somford, D. M., van der Poel, H. G., Wijburg, C. J., Wijsman, B. P., Hoekstra, R. J., van Moorselaar, R. J. A., van Bezooijen, B. P. J., Meijer, R. P., Busstra, M. B., van den Berg, H. P., Robbrecht, D. G. J. & Doornweerd, B. H. J. & 2 others, , 15 Feb 2026, In: International Journal of Cancer. 158, 4, p. 984-993 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Molecular subtyping of advanced bladder cancer patients and patient-derived organoids based on a 3-marker immunohistochemistry approach to evaluate chemotherapy sensitivity
Viergever, B. J., Zuidema, A. C., Jonges, T., Van Schelven, S. J., Westland, D., Kalkhoven, E., Kranenburg, O. & Meijer, R. P., Jan 2026, In: Urologic Oncology: Seminars and Original Investigations. 44, 1, p. 64.e15-64.e25 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
Nieuwe ontwikkelingen bij blaaskanker
Translated title of the contribution :New developments in bladder cancer Research output: Contribution to journal › Editorial › Academic › peer-review
Open AccessFile -
The impact of positive surgical margins after cystectomy on oncological outcomes: a nationwide study from the Prospective Bladder Cancer Infrastructure (ProBCI)
Bosveld, J., Nguyen, T. Q., Boormans, J. L., van der Heijden, A. G., Mehra, N., Kiemeney, L. A., Aben, K. K. H., Meijer, R. P., Richters, A. & ProBCI Study Group, 2026, In: Tijdschrift voor Urologie. 16Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile
Activities
-
Global Congress on Bladder Cancer 2022
Meijer, R. (Invited speaker)
20 Oct 2022Activity: Participating in or organising an event › Participation in workshop, seminar, course › Academic
-
Neoadjuvant/inductie systemische behandeling gevolgd door blaassparende behandeling
Meijer, R. (Speaker)
22 Apr 2022Activity: Talk or presentation › Invited talk › Professional
-
-Complications after RC and management -Ureter/bowel anastomosis strictures: video’s reimplantation versus endo dilatation
Meijer, R. (Speaker)
8 Apr 2022Activity: Talk or presentation › Invited talk › Academic
-
Urothelial cancer organoids: a tool for bladder cancer research
Meijer, R. (Speaker)
10 Jun 2021Activity: Talk or presentation › Invited talk › Academic
-
European Association of Urology (External organisation)
Meijer, R. (Member)
19 Mar 2021Activity: Membership › Membership of guideline committee › Professional